(Q30326042)

18 June 2017

1 reference

title

Recent progress in anti-influenza chemotherapy. (English)

1 reference

18 June 2017

0 references

Shigeta S

1

1 reference

18 June 2017

publication date

1 September 1999

1 reference

18 June 2017

1 reference

18 June 2017

volume

2

1 reference

18 June 2017

issue

3

1 reference

18 June 2017

page(s)

153-164

1 reference

Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus

18 June 2017

cites work

1 reference

12 December 2020

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

1 reference

12 December 2020

Antiviral activity of alpha-methyl-1-adamantanemethylamine hydrochloride

1 reference

12 December 2020

Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group

1 reference

12 December 2020

Effects of protease inhibitors on replication of various myxoviruses

1 reference

12 December 2020

Inhibition of influenza virus infections in mice by GS4104, an orally effective influenza virus neuraminidase inhibitor

1 reference

12 December 2020

A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection

1 reference

12 December 2020

Potent inhibition of respiratory syncytial virus by polyoxometalates of several structural classes

1 reference

12 December 2020

Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness

1 reference

12 December 2020

Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en.

1 reference

12 December 2020

Biochemistry and clinical applications of ribavirin

1 reference

12 December 2020

Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds

1 reference

12 December 2020

Penetration of GS4071, a novel influenza neuraminidase inhibitor, into rat bronchoalveolar lining fluid following oral administration of the prodrug GS4104.

1 reference

12 December 2020

Molecular mechanism underlying the action of a novel fusion inhibitor of influenza A virus

1 reference

12 December 2020

Comparative inhibitory effects of various nucleoside and nonnucleoside analogues on replication of influenza virus types A and B in vitro and in ovo.

1 reference

12 December 2020

Influenza virus resistance to neuraminidase inhibitors

1 reference

12 December 2020

Safety and efficacy of long-term use of rimantadine for prophylaxis of type A influenza in nursing homes

1 reference

12 December 2020

Oral ribavirin treatment of influenza A and B.

1 reference

12 December 2020

Antisense oligonucleotides directed against the viral RNA polymerase gene enhance survival of mice infected with influenza A.

1 reference

12 December 2020

Rational design of potent sialidase-based inhibitors of influenza virus replication

1 reference

12 December 2020

Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections

1 reference

12 December 2020

Specific inhibition of influenza virus RNA polymerase and nucleoprotein gene expression by liposomally encapsulated antisense phosphorothioate oligonucleotides in MDCK cells

1 reference

12 December 2020

A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection

1 reference

12 December 2020

Intravenous ribavirin by constant infusion for serious influenza and parainfluenzavirus infection.

1 reference

12 December 2020

SEROLOGICAL EVIDENCE FOR PREVENTION OF INFLUENZAL INFECTION IN VOLUNTEERS BY AN ANTI-INFLUENZAL DRUG ADAMANTANAMINE HYDROCHLORIDE

1 reference

12 December 2020

Synergistic anti-influenza virus A (H1N1) activities of PM-523 (polyoxometalate) and ribavirin in vitro and in vivo

1 reference

12 December 2020

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

1 reference

12 December 2020

Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance

1 reference

12 December 2020

10.2165/00126839-199902030-00001

Identifiers

DOI

1 reference

18 June 2017

0 references

1 reference